This website uses cookies. By continuing you are agreeing to our privacy policy.

David Shechter, Ph.D.

headshot of Shecter
Albert Einstein College of Medicine, Inc.
Funded by LUNG FORCE
When the Writing Goes Wrong: Protein Arginine Methyltransferases in Lung Cancer

Protein modification by methylation, the addition of a small chemical flag that regulates that protein's function, is frequently disrupted in lung cancer. Our proposal aims to understand why a class of enzymes that adds a methyl group to protein building blocks called arginine is disrupted in lung cancer cells and importantly how drugging these enzymes could be a novel chemotherapy. We will test, in lung cancer cells, specific drugs against these enzymes, one of which is currently in phase I trials, in combination with a range of other drugs to understand how they could work in combination. We will also probe specific and important molecular events that are regulated by these enzymes, in lung cancer cells. The information we develop from this study will potentially lead to improved chemotherapeutic approaches in lung and other human cancers.

Red button with telephone
Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
Red button of two hand prints
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.

Button of turquoise LUNG FORCE swirl
What is LUNG FORCE?

LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.